Literature DB >> 33576497

Prevention of conjunctivitis in patients with atopic dermatitis undergoing treatment with dupilumab: an Italian single-centre experience.

O Simonetti1, G Radi1, F Diotallevi1, E Molinelli1, G Rizzetto1, A Offidani1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33576497     DOI： 10.1111/ced.14611

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN： 0307-6938            Impact factor:   3.470


× No keyword cloud information.
  2 in total

1.  Identification of Risk Factors for Dupilumab-associated Ocular Surface Disease in Patients with Atopic Dermatitis.

Authors:  Roselie E Achten; Chantal Van Luijk; Lisa Van der Rijst; Daphne Bakker; Lotte Spekhorst; Nicolaas Zuithoff; Marie Schuttelaar; Geertruida Romeijn; Angelique Voorberg; Marijke Kamsteeg; Inge Haeck; Marlies De Graaf; Judith Thijs; Joke De Boer; Marjolein De Bruin-Weller
Journal:  Acta Derm Venereol       Date:  2022-03-11       Impact factor: 3.875

Review 2.  Recommendations for dermatologists treating patients with atopic dermatitis during the Covid-19 pandemic: a look into the past for a conscious vaccination management.

Authors:  Oriana Simonetti; Giulia Radi; Elisa Molinelli; Giulio Rizzetto; Federico Diotallevi; Annamaria Offidani
Journal:  Hum Vaccin Immunother       Date:  2021-06-25       Impact factor: 4.526
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.